Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.
Source check: Source checked. Not independent scientific confirmation.
Finding: The primary study applies supervised CNN segmentation/quantification to tumor-infiltrating lymphocytes in luminal breast cancer and reports outcome associations in discovery/test and external cohorts. Preserve the mixed finding: tTIL results were prognostic while AI-derived sTIL proportion was not. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: Publisher PDF, original Methods/Results: Nottingham discovery/test cohorts (1,572/659) and external cohort (318); model-derived spatial TIL measures and reported survival associations.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Publisher PDF, original Methods/Results: Nottingham discovery/test cohorts (1,572/659) and external cohort (318); model-derived spatial TIL measures and reported survival associations.
- Test and result
- Publisher PDF, original Methods/Results: Nottingham discovery/test cohorts (1,572/659) and external cohort (318); model-derived spatial TIL measures and reported survival associations.
- Limitation / still unknown
- Publisher PDF, original Methods/Results: Nottingham discovery/test cohorts (1,572/659) and external cohort (318); model-derived spatial TIL measures and reported survival associations.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s41416-023-02451-3.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.